FierceBiotech 2026年3月18日 Beyond seizures: With experimental drug, Stoke aims to restore developmental loss in Dravet syndrome
FierceBiotech 2026年3月18日 JenaValve's Trilogy valve secures FDA's 1st approval in aortic regurgitation
FierceBiotech 2026年3月17日 Xaira exec divulges R&D focus, how $1B fundraise fuels AI-driven hunt for what the 'industry is hungriest for'
FierceBiotech 2026年3月17日 FDA rejects Aldeyra dry eye disease drug for 3rd time, citing inconsistent study findings
FierceBiotech 2026年3月17日 Hitting regulatory roadblock, Bicycle pumps brakes on lead program and deflates headcount by 30%
FierceBiotech 2026年3月17日 R1 zooms out of stealth with $77.5M series A to advance chronic kidney disease treatment
FierceBiotech 2026年3月17日 Roche inks Nvidia deal to bolster AI factory, speed up drug and diagnostic development
FierceBiotech 2026年3月16日 Astellas walks away from $1.6B biobucks T-cell engager pact with CytomX after 6 years